HomeCompareOBYCF vs MRK

OBYCF vs MRK: Dividend Comparison 2026

OBYCF yields 2.12% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 OBYCF wins by $81.78M in total portfolio value· pulled ahead in Year 2
10 years
OBYCF
OBYCF
● Live price
2.12%
Share price
$23.85
Annual div
$0.50
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$81.84M
Annual income
$75,024,784.10
Full OBYCF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — OBYCF vs MRK

📍 OBYCF pulled ahead of the other in Year 2

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodOBYCFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, OBYCF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
OBYCF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

OBYCF
Annual income on $10K today (after 15% tax)
$179.79/yr
After 10yr DRIP, annual income (after tax)
$63,771,066.48/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, OBYCF beats the other by $63,762,738.07/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of OBYCF + MRK for your $10,000?

OBYCF: 50%MRK: 50%
100% MRK50/50100% OBYCF
Portfolio after 10yr
$40.95M
Annual income
$37,517,291.12/yr
Blended yield
91.62%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

OBYCF
No analyst data
Altman Z
2.5
Piotroski
6/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

OBYCF buys
0
MRK buys
0
No recent congressional trades found for OBYCF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricOBYCFMRK
Forward yield2.12%2.76%
Annual dividend / share$0.50$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%32.7%
Portfolio after 10y$81.84M$56.8K
Annual income after 10y$75,024,784.10$9,798.13
Total dividends collected$81.30M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: OBYCF vs MRK ($10,000, DRIP)

YearOBYCF PortfolioOBYCF Income/yrMRK PortfolioMRK Income/yrGap
1$11,123$423.04$11,206$366.19$83.00MRK
2← crossover$12,781$879.52$12,650$502.35+$131.00OBYCF
3$15,565$1,889.03$14,407$694.19+$1.2KOBYCF
4$20,954$4,299.93$16,585$967.82+$4.4KOBYCF
5$33,241$10,820.22$19,342$1,363.89+$13.9KOBYCF
6$67,652$32,083.90$22,913$1,947.19+$44.7KOBYCF
7$194,437$122,049.54$27,662$2,823.89+$166.8KOBYCF
8$863,710$655,662.35$34,159$4,173.35+$829.6KOBYCF
9$6,368,129$5,443,958.69$43,337$6,308.80+$6.32MOBYCF
10$81,838,682$75,024,784.10$56,776$9,798.13+$81.78MOBYCF

OBYCF vs MRK: Complete Analysis 2026

OBYCFStock

Obayashi Corporation engages in the construction business in Japan, North America, Asia, the Middle East, Europe, and Oceania. The company constructs buildings, including offices, condominiums, commercial facilities, factories, hospitals, and schools; and civil engineering projects, such as tunnels, bridges, dams, river works, urban civil engineering structures, railroads, and expressways. It is also involved in the development and leasing of real estate properties in various locations, primarily in urban areas, as well as property management activities; solar, biomass, hydropower, geothermal, and wind power generation business; and PPP and agriculture business. In addition, the company sells materials and equipment for construction; develops and sells computer software; sells and leases electronic equipment; offers monetary lending, debt guarantee, ownership and management of securities, and debt purchasing; and non-life insurance agency business. Further, it engages in the provision of urban development, contracted engineering, management, consultancy services, etc.; and is involved in the M&E design and construction activities. The company was founded in 1892 and is headquartered in Tokyo, Japan.

Full OBYCF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this OBYCF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

OBYCF vs SCHDOBYCF vs JEPIOBYCF vs OOBYCF vs KOOBYCF vs MAINOBYCF vs JNJOBYCF vs ABBVOBYCF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.